Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0000950123-06-003658
Filing Date
2006-03-24
Accepted
2006-03-24 17:16:07
Documents
8
Effectiveness Date
2006-03-24

Document Format Files

Seq Description Document Type Size
1 FORM S-3 y19004sv3asr.htm S-3ASR 638341
2 EX-5.1: OPINION OF SAUL EWING LLP y19004exv5w1.htm EX-5.1 5009
3 EX-12.1: COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES y19004exv12w1.htm EX-12.1 13279
4 EX-23.1: CONSENT OF KPMG LLP y19004exv23w1.htm EX-23.1 2942
5 EX-25.1: STATEMENT OF ELIGIBILITY ON FORM T-1 y19004exv25w1.htm EX-25.1 37425
7 GRAPHIC y19004y1900400.gif GRAPHIC 1937
8 GRAPHIC y19004y1900401.gif GRAPHIC 2152
9 GRAPHIC y19004y1900402.gif GRAPHIC 2842
  Complete submission text file 0000950123-06-003658.txt   708489
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-132718 | Film No.: 06710055
SIC: 2835 In Vitro & In Vivo Diagnostic Substances